MX9304624A - Compuestos poliazamacrociclicos para complejamien to de iones metalicos. - Google Patents

Compuestos poliazamacrociclicos para complejamien to de iones metalicos.

Info

Publication number
MX9304624A
MX9304624A MX9304624A MX9304624A MX9304624A MX 9304624 A MX9304624 A MX 9304624A MX 9304624 A MX9304624 A MX 9304624A MX 9304624 A MX9304624 A MX 9304624A MX 9304624 A MX9304624 A MX 9304624A
Authority
MX
Mexico
Prior art keywords
polyazamacrocycle
compounds
ion complex
metallic ion
magnetic resonance
Prior art date
Application number
MX9304624A
Other languages
English (en)
Inventor
Allan Dean Sherry
Gary E Kiefer
Original Assignee
Univ Texas
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/662,075 external-priority patent/US4639365A/en
Application filed by Univ Texas, Dow Chemical Co filed Critical Univ Texas
Publication of MX9304624A publication Critical patent/MX9304624A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

La presente invención se relaciona con un nuevo compuesto poliazamacrolítico ó una sal del mismo y con sus usos como agentes específico tisular. El compuesto presenta fórmula: ([CH2]xNR) y donde x es 2, 3 ó una combinación de p 2(s) y q(s) en donde p + q y; y es 3 ó 4; R es (CH2)zP(O)OR1OR; R1 es H o CH3; R2 es C³H1+2n; n es 4 a 6; z es 1 a 3. Es una realización importante, este compuesto puede formar un complejo con un metal para resultar en un complejo de compuesto poliazamacrocíclico con la fórmula: ([CH2]xNR) y M+r, donde R es 2 ó 3; y M es un ión metálico, incluso un lantánido, un metal pesado ó un metal radionúclido.
MX9304624A 1984-10-18 1993-07-30 Compuestos poliazamacrociclicos para complejamien to de iones metalicos. MX9304624A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/662,075 US4639365A (en) 1984-10-18 1984-10-18 Gadolinium chelates as NMR contrast agents
US07/923,715 US5362476A (en) 1984-10-18 1992-07-31 Alkyl phosphonate polyazamacrocyclic cheates for MRI

Publications (1)

Publication Number Publication Date
MX9304624A true MX9304624A (es) 1994-08-31

Family

ID=34922820

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304624A MX9304624A (es) 1984-10-18 1993-07-30 Compuestos poliazamacrociclicos para complejamien to de iones metalicos.

Country Status (19)

Country Link
US (2) US5362476A (es)
EP (2) EP0652885B1 (es)
JP (1) JP3411919B2 (es)
CN (1) CN1040750C (es)
AT (2) ATE209211T1 (es)
AU (1) AU4654893A (es)
CA (1) CA2140557A1 (es)
DE (2) DE69331203T2 (es)
DK (1) DK0855401T3 (es)
ES (1) ES2167667T3 (es)
FI (1) FI950397A (es)
HU (1) HUT70447A (es)
IL (1) IL106164A0 (es)
MX (1) MX9304624A (es)
NO (1) NO306466B1 (es)
PH (1) PH30934A (es)
PT (1) PT855401E (es)
WO (1) WO1994003464A1 (es)
ZA (1) ZA935541B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714604A (en) * 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
EP0841951A2 (en) * 1995-06-26 1998-05-20 Concat Ltd. Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US5952732A (en) * 1997-11-10 1999-09-14 Scarpitti; Ernest A Vehicle security system
CA2382057A1 (en) * 1999-09-13 2001-03-22 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
EP1362861B1 (en) * 1999-09-13 2005-12-14 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
US7189504B2 (en) * 2000-08-07 2007-03-13 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
US7338651B2 (en) * 2001-09-04 2008-03-04 Texas Tech University System Multi-use multimodal imaging chelates
US20030133872A1 (en) * 2001-10-22 2003-07-17 Kiefer Garry E. Radiopharmaceutical agent for the treatment of early stage cancer
EP1481268A4 (en) * 2002-02-07 2005-06-29 Covalent Partners Llc NANOFILM AND MEMBRANE COMPOSITIONS
US20040034223A1 (en) * 2002-02-07 2004-02-19 Covalent Partners, Llc. Amphiphilic molecular modules and constructs based thereon
US20040106741A1 (en) * 2002-09-17 2004-06-03 Kriesel Joshua W. Nanofilm compositions with polymeric components
EP1778699A4 (en) * 2004-08-10 2009-02-25 Dow Global Technologies Inc TARGETING OF CHELANTS AND CHELATES
JP5345945B2 (ja) 2006-12-11 2013-11-20 ブラッコ・イメージング・ソシエタ・ペル・アチオニ フィブリン結合ペプチドおよびそのコンジュゲート
EP2476703A1 (en) 2011-01-14 2012-07-18 Bracco Imaging S.p.A Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
US7595699B1 (en) * 2008-03-04 2009-09-29 Freescale Semiconductor, Inc. Look loop circuit and method having improved lock time
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
BR112013000236B1 (pt) * 2010-07-06 2018-11-13 Catexel Limited método de produzir um composto, e, sal protonado
WO2012095516A1 (en) 2011-01-14 2012-07-19 Bracco Imaging Spa Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
BR112018015143A2 (pt) 2016-02-09 2018-12-18 Bracco Suisse Sa proteína quimérica recombinante para direcionamento de selectinas

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932451A (en) * 1973-11-27 1976-01-13 E. I. Du Pont De Nemours & Company 1,4,7,10-Tetraazatetracyclo[5.5.1.04,13.010,13 ]tridecane and its conjugate acids
US3930867A (en) * 1974-01-07 1976-01-06 E. I. Du Pont De Nemours And Company Macrocyclic polyamines as sensitizers for silver halide emulsions
US4038312A (en) * 1975-08-22 1977-07-26 E. I. Du Pont De Nemours And Company Tricyclic phosphorous triamides
US3996276A (en) * 1975-08-22 1976-12-07 E. I. Du Pont De Nemours And Company Bicyclic and tricyclic phosphorous triamides
US3987128A (en) * 1975-08-22 1976-10-19 E. I. Du Pont De Nemours And Company Tetracyclic tetraamino phosphoranes and method of preparation
US4085106A (en) * 1976-01-07 1978-04-18 E. I. Du Pont De Nemours And Company Bicyclic and tricyclic trisaminomethanes
DE2740170C2 (de) * 1977-05-17 1982-02-04 Tabushi, Iwao, Kyoto Alkylsubstituierte cyclische Tetraalkylentetramine
US4337154A (en) * 1979-04-04 1982-06-29 Nippon Shokubai Kagaku Kogyo Co., Ltd. Crosslinked composite semipermeable membrane
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4432907A (en) * 1979-09-10 1984-02-21 Analytical Radiation Corporation Diamine acid fluorescent chelates
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4421671A (en) * 1982-06-18 1983-12-20 General Electric Company Rare-earth-doped yttria-gadolinia ceramic scintillators
SU1081169A1 (ru) * 1982-12-13 1984-03-23 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова @ , @ , @ -Трис(диоксифосфорилметил)-1,4,7-триазациклононан в качестве комплексона дл селективного св зывани катионов магни ,цинка,меди,никел
US4731239A (en) * 1983-01-10 1988-03-15 Gordon Robert T Method for enhancing NMR imaging; and diagnostic use
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US4775522A (en) * 1983-03-04 1988-10-04 Children's Hospital Research Foundation, A Division Of Children's Hospital Medical Center NMR compositions for indirectly detecting a dissolved gas in an animal
CA1317937C (en) * 1984-10-18 1993-05-18 A. Dean Sherry Gadolinium chelates with carboxymethyl derivatives of polyazamacrocycles as nmr contrast agents
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US5342606A (en) * 1984-10-18 1994-08-30 Board Of Regents, The University Of Texas System Polyazamacrocyclic compounds for complexation of metal ions
DE3772785D1 (de) * 1986-01-23 1991-10-17 Squibb & Sons Inc 1-substituiertes-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecan und analoga.
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
BR8907277A (pt) * 1988-12-22 1991-03-26 Dow Chemical Co Processo para preparar poliazamacrociclos mono-n-alquilados
GB8903023D0 (en) * 1989-02-10 1989-03-30 Parker David Chemical compounds
GB8914543D0 (en) * 1989-06-23 1989-08-09 Parker David Chemical compounds
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
CN1040750C (zh) 1998-11-18
FI950397A0 (fi) 1995-01-30
ATE209211T1 (de) 2001-12-15
DK0855401T3 (da) 2002-05-21
IL106164A0 (en) 1993-10-20
ZA935541B (en) 1994-02-24
PH30934A (en) 1997-12-23
PT855401E (pt) 2002-04-29
DE69320481D1 (de) 1998-09-24
EP0855401B1 (en) 2001-11-21
DE69320481T2 (de) 1999-03-18
JP3411919B2 (ja) 2003-06-03
AU4654893A (en) 1994-03-03
CN1084514A (zh) 1994-03-30
EP0855401A1 (en) 1998-07-29
ATE169827T1 (de) 1998-09-15
NO950346L (no) 1995-01-30
WO1994003464A1 (en) 1994-02-17
HU9500283D0 (en) 1995-03-28
ES2167667T3 (es) 2002-05-16
DE69331203T2 (de) 2002-05-08
CA2140557A1 (en) 1994-02-17
EP0652885B1 (en) 1998-08-19
DE69331203D1 (de) 2002-01-03
US5362476A (en) 1994-11-08
EP0652885A1 (en) 1995-05-17
JPH08500346A (ja) 1996-01-16
NO950346D0 (no) 1995-01-30
HUT70447A (en) 1995-10-30
NO306466B1 (no) 1999-11-08
FI950397A (fi) 1995-01-30
US5630997A (en) 1997-05-20

Similar Documents

Publication Publication Date Title
MX9304624A (es) Compuestos poliazamacrociclicos para complejamien to de iones metalicos.
MX9102116A (es) Compuestos poliazamacrociclicos para la complejacion de iones metalicos.
DE69430730D1 (de) Hepatobillianische magnetische resonanz-kontrastmittel
MX205459A (es) Agentes de contraste para resonancia magnetica nuclear y proceso para su preparacion
NO873237D0 (no) Fremgangsmaate ved nmr-avbilding.
ES527954A1 (es) Un procedimiento para preparar isoxazoles
GB8817137D0 (en) Compositions
CA1259998C (es)
ZA846093B (en) Heptaose compounds,preparation and use thereof
ES505328A0 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos
ES2021944A6 (es) Procedimiento para preparar nuevos derivados de 1,3,5,-triamino-2,4,6-triyodobenceno.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees